Delavirdine mesylate - CAS 147221-93-0
Catalog number: 147221-93-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C23H32N6O6S2
Molecular Weight:
552.67
COA:
Inquire
Targets:
HIV
Description:
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Rescriptor; U 90152
MSDS:
Inquire
1. Clinical Implications of CNS Penetration of Antiretroviral Drugs
Heather E. Wynn, Richard C. Brundage and Courtney V. Fletcher. CNS Drugs 2002; 16 (9): 595-609
Delavirdine mesylate, nevirapine and efavirenz are the three currently marketed NNRTIs. As mentioned in section 2, the plasma protein binding of this class of agents varies, from>95%for delavirdine mesylate and efavirenz to approximately 60% for nevirapine. There are limited published data on the CSF penetration of this class of compounds (table II). Of the three available NNRTIs, delavirdine mesylate is the least often used in routine clinical practice because of its inconvenient administration schedule and toxicity profile. The available clinical data on CSF penetration focus on nevirapine and efavirenz. In clinical studies, both nevirapine and efavirenz are detected in the CSF up to 20 hours postdose as a result of their long elimination half-lives. For both antivirals, the CSF concentrations are variable and display a time-dependent decrease. In contrast, the CSF-to-plasma concentration ratios increase over the duration of the dose interval, a reflection of faster elimination from the central compartment.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Products


CAS 129618-40-2 Nevirapine

Nevirapine
(CAS: 129618-40-2)

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.

CAS 144217-65-2 YYA-021

YYA-021
(CAS: 144217-65-2)

YYA-021 enhances the neutralization sensitivity of simian-human immunodeficiency virus (SHIV) carrying the envelope from the clade B clinical human immunodefici...

CAS 127779-20-8 Saquinavir

Saquinavir
(CAS: 127779-20-8)

A selective HIV protease inhibitor. Antiviral.

CAS 697761-98-1 Elvitegravir

Elvitegravir
(CAS: 697761-98-1)

Elvitegravir (EVG, JTK-303/GS-9137) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.

CAS 134678-17-4 Lamivudine

Lamivudine
(CAS: 134678-17-4)

Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS.

BMS-488043
(CAS: 452296-83-2)

BMS-488043 is a small-molecule HIV fusion inhibitor.

CAS 226700-81-8 Fosamprenavir Calcium Salt

Fosamprenavir Calcium Salt
(CAS: 226700-81-8)

HIV protease inhibitor; water soluble prodrug of amprenavir.

CAS 269055-15-4 Etravirine

Etravirine
(CAS: 269055-15-4)

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase i...

CAS 159989-65-8 Nelfinavir Mesylate

Nelfinavir Mesylate
(CAS: 159989-65-8)

Nelfinaviris a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor.

CAS 729607-74-3 BMS-707035

BMS-707035
(CAS: 729607-74-3)

BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM.

PNU-104489
(CAS: 177577-60-5)

PNU-104489, a sulfonamidoindol derivative, has been found to be a HIV-1 specific inhibitor and was proved to exhibit activity against BHA-P-resistant HIV-1MF ha...

CAS 1415559-43-1 CDK9-IN-1

CDK9-IN-1
(CAS: 1415559-43-1)

Among CDKs, CDK9 is a validated pathological target in HIV infection, inflammation and cardiac hypertrophy; however selective CDK9 inhibitors are still not avai...

CAS 206361-99-1 Darunavir

Darunavir
(CAS: 206361-99-1)

Darunavir is a second generation protease inhibitor that targets the HIV-1 protease. It demonstrates extremely potent activity against the infectivity and repli...

CAS 869901-69-9 MK-2048

MK-2048
(CAS: 869901-69-9)

MK-2048 is a second generation integrase inhibitor (IC50=2.6 nM). It can inhibits the HIV enzyme integrase 4 times longer than raltegravir.

CAS 60940-34-3 Ebselen

Ebselen
(CAS: 60940-34-3)

Ebselen, also known as SPI-1005, is an organoselenium compound with potential anti-oxidant, anti-inflammatory and cytoprotective activity. Upon oral administra...

CAS 864953-29-7 BMS-663068

BMS-663068
(CAS: 864953-29-7)

BMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection. It is a prodrug for BMS-626529, which binds to the viral envelo...

CAS 149488-17-5 Trovirdine

Trovirdine
(CAS: 149488-17-5)

Trovirdine, a thiourea non-nucleoside reverse transcriptase inhibitor, was shown to inhibits HIV-1 RT when employing heteropolymeric primer/template (oligo-DNA/...

GSK2838232
(CAS: 1443460-91-0)

GSK2838232, a derivative of Betulin, is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection.

CAS 1155419-89-8 BI 224436

BI 224436
(CAS: 1155419-89-8)

BI 224436 is a novel HIV-1 non-catalytic-site integrase inhibitor; has antiviral EC50s of <15 nM against different HIV-1 laboratory strains and cellular cytotox...

CAS 500287-72-9 Rilpivirine

Rilpivirine
(CAS: 500287-72-9)

A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic...

Chemical Structure

CAS 147221-93-0 Delavirdine mesylate

Quick Inquiry

Verification code

Featured Items